Last updated: 02/07/2020 16:40:10
Retrospective survey of lasting, treatment-free responders with ITP after cessation of drug therapy(RELIANT). Preliminary survey.RELIANT
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: Retrospective survey of lasting, treatment-free responders with ITP after cessation of drug therapy(RELIANT). Preliminary survey.
Trial description: The purpose of this preliminary survey is to identify the numbers and treatment place of adult ITP patients with sustained platelet counts without any ITP treatment after cessation of ITP medical treatment in Japan.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Number of chronic ITP patients
Timeframe: After 6 months
Secondary outcomes:
Number of chronic ITP patients
Timeframe: After 6 months
Interventions:
Not applicable
Enrollment:
0
Primary completion date:
2015-08-05
Observational study model:
Case-Only
Time perspective:
Retrospective
Clinical publications:
Not applicable
Medical condition
Thrombocytopaenia
Product
eltrombopag
Collaborators
Not applicable
Study date(s)
March 2015 to May 2015
Type
Observational
Phase
Not applicable
Participation criteria
Sex
Female & Male
Age
20+ years
Accepts healthy volunteers
none
- Chronic ITP patients in adults.
- Long-lasting treatment-free patients after termination of its medical therapy for ITP.
- Responder to splenectomy or H pylori eradication.
Inclusion and exclusion criteria
Inclusion criteria:
- Chronic ITP patients in adults.
- Long-lasting treatment-free patients after termination of its medical therapy for ITP.
Exclusion criteria:
- Responder to splenectomy or H pylori eradication.
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Refer to study documents
Recruitment status
Study complete
Actual primary completion date
2015-08-05
Actual study completion date
2015-08-05
Plain language summaries
Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website